BIOT
•
Equity
L&G PHARMA BREAKTHROUGH UCITS ETF
TER (bps):
49
AUM (USD m):
30
ISIN:
IE00BF0H7608
Domicile:
Ireland
Share Class Currency:
USD
ESG:
No
Geographical Focus:
Global
As of:
17 Nov 2023
Climate Fund:
No
Benchmark
The Solactive Pharma Breakthrough Value Index aims to track the performance of a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. it uses a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts. The Index selects stocks that meet certain size and liquidity requirements.
RELATED ARTICLES
MOST READ
1
Analysis
State Street’s S&P 500 ETF nets €1bn inflows following fee cut
2
Analysis
MSCI accused of ‘conflicts of interest’ in ESG ratings
3
New Listing
DWS unveils fixed maturity euro corporate bond ETF range
4
New Listing
DWS launches physical carbon ETC
5
Industry Updates